Company Filing History:
Years Active: 2009
Introduction
Cesar Mattei is an innovative inventor based in Herts, GB, recognized for his contributions to the field of neuroprotection. With a keen focus on treating glutamate cytotoxicity, Mattei's work aims to address significant health challenges related to neurological disorders.
Latest Patents
Cesar Mattei holds a patent for his work titled "Methods for treating glutamate cytotoxicity with beta-naphthoquinone compounds." This patent outlines the use of beta-naphthoquinone derivatives, along with their salts, for the prevention and treatment of glutamate cytotoxicity. The invention further explores the potential of these compounds to prevent and treat neurological disorders induced by glutamate. Additionally, the patent discusses the formulation of drugs designed to inhibit the release of glutamate, highlighting the therapeutic potential of these innovative compounds.
Career Highlights
Mattei is affiliated with the Centre National de la Recherche Scientifique, where he collaborates with other esteemed researchers to advance scientific knowledge and develop effective treatments for neurological conditions. His commitment to research and innovation has positioned him as a notable figure in his field.
Collaborations
Throughout his career, Cesar Mattei has collaborated with prominent scientists Maurice Israel and Jordi Molgo. Their partnerships have contributed to important advancements in understanding and treating glutamate-related neurological issues.
Conclusion
Cesar Mattei's innovative approach to addressing glutamate cytotoxicity through beta-naphthoquinone compounds represents a significant step forward in neuroprotective research. With his valuable contributions and collaborations, he continues to be a key player in the quest for effective treatments for neurological disorders.